Bioretec Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Public

  • Employees
  • 58

Employees

  • Stock Symbol
  • BRETEC

Stock Symbol

  • Share Price
  • $0.03
  • (As of Thursday Closing)

Bioretec General Information

Description

Bioretec Ltd is a medical device company focusing on the development of bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. It has developed the following product lines: RemeOs and Activa. RemeOs is based on a high-performance magnesium alloy and hybrid composite, introducing absorbable materials for enhanced surgical outcomes. The RemeOs implants (RemeOs Screw Lag, RemeOs Screw Lag Solid, RemeOs Screw FT, etc.) are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The Activa implants (ActivaPin, ActivaNail, ActivaScrew, etc.) are based on fully absorbable biopolymer products that facilitate natural bone healing without requiring removal surgery.

Contact Information

Formerly Known As
BCI Bioabsorbable Concepts
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Yrittäjänkulma 5
  • 33710 Tampere
  • Finland
+358 020
Primary Industry
Therapeutic Devices
Stock Exchange
HEL
Vertical(s)
Corporate Office
  • Yrittäjänkulma 5
  • 33710 Tampere
  • Finland
+358 020

Bioretec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioretec Stock Performance

As of 12-Nov-2026, Bioretec’s stock price is $0.03. Its current market cap is $33.6M with 1.34B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.01 - $0.10 $33.6M 1.34B 1.58M -$0.03

Bioretec Financials Summary

As of 30-Jun-2026, Bioretec has a trailing 12-month revenue of $4.4M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 29,799 12,372 56,220 43,557
Revenue 4,395 3,972 4,917 4,227
EBITDA (8,800) (9,561) (4,386) (3,066)
Net Income (9,954) (10,697) (4,992) (4,100)
Total Assets 23,373 13,718 11,940 11,780
Total Debt 0 510 698 1,156
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bioretec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bioretec‘s full profile, request access.

Request a free trial

Bioretec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bioretec Ltd is a medical device company focusing on the development of bioabsorbable and bioresorbable implants for ped
Therapeutic Devices
Tampere, Finland
58 As of 2026

Tampere, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bioretec Competitors (1)

One of Bioretec’s competitors is Inion (Healthcare Devices and Supplies), a Formerly VC-backed company based in Tampere, Finland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inion (Healthcare Devices and Supplies) Formerly VC-backed Tampere, Finland
You’re viewing 1 of 1 competitors. Get the full list »

Bioretec Patents

Bioretec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024275705-A1 An orthopedic implant or a part thereof, a method for preparing thereof, a method for preparing biodegradable magnesium alloy and use of biodegradable magnesium alloy Pending 24-May-2023
EP-4467166-A1 An orthopedic implant or a part thereof, a method for preparing thereof, a method for preparing biodegradable magnesium alloy and use of biodegradable magnesium alloy Active 24-May-2023
EP-4467166-B1 An orthopedic implant or a part thereof, a method for preparing thereof, a method for preparing biodegradable magnesium alloy and use of biodegradable magnesium alloy Active 24-May-2023
ES-3055334-T3 An orthopedic implant or a part thereof, a method for preparing thereof, a method for preparing biodegradable magnesium alloy and use of biodegradable magnesium alloy Active 24-May-2023
WO-2024240625-A1 An orthopedic implant or a part thereof, a method for preparing thereof, a method for preparing biodegradable magnesium alloy and use of biodegradable magnesium alloy Inactive 24-May-2023 A61L27/047
To view Bioretec’s complete patent history, request access »

Bioretec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioretec Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bioretec‘s full profile, request access.

Request a free trial

Bioretec ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Bioretec’s complete esg history, request access »

Bioretec FAQs

  • When was Bioretec founded?

    Bioretec was founded in 1985.

  • Where is Bioretec headquartered?

    Bioretec is headquartered in Tampere, Finland.

  • What is the size of Bioretec?

    Bioretec has 58 total employees.

  • What industry is Bioretec in?

    Bioretec’s primary industry is Therapeutic Devices.

  • Is Bioretec a private or public company?

    Bioretec is a Public company.

  • What is Bioretec’s stock symbol?

    The ticker symbol for Bioretec is BRETEC.

  • What is the current stock price of Bioretec?

    As of 12-Nov-2026 the stock price of Bioretec is $0.03.

  • What is the current market cap of Bioretec?

    The current market capitalization of Bioretec is $33.6M.

  • What is Bioretec’s current revenue?

    The trailing twelve month revenue for Bioretec is $4.4M.

  • Who are Bioretec’s competitors?

    Inion (Healthcare Devices and Supplies) is a competitor of Bioretec.

  • What is Bioretec’s annual earnings per share (EPS)?

    Bioretec’s EPS for 12 months was -$0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process